LS Investment Advisors’s AMAG Pharmaceuticals AMAG Stock Holding History

LS Investment Advisors’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1,028	Closed	-$8K	–	1612
2020 Q2	$8K	Hold	1,028	–	–	﹤0.01%	1562
2020 Q1	$6K	Hold	1,028	–	–	﹤0.01%	1634
2019 Q4	$13K	Hold	1,028	–	–	﹤0.01%	1625
2019 Q3	$12K	Hold	1,028	–	–	﹤0.01%	1623
2019 Q2	$10K	Hold	1,028	–	–	﹤0.01%	1646
2019 Q1	$13K	Buy	+1,028	New	+$15.3K	﹤0.01%	1592
2017 Q4	–	Sell	-4,401	Closed	-$81K	–	1897
2017 Q3	$81K	Buy	4,401 +1,306	+42%	+$24.3K	﹤0.01%	1215
2017 Q2	$57K	Hold	3,095	–	–	﹤0.01%	1313
2017 Q1	$70K	Buy	+3,095	New	+$74.1K	﹤0.01%	1237
2016 Q2	–	Sell	-1,300	Closed	-$30K	–	1877
2016 Q1	$30K	Buy	+1,300	New	+$30.9K	﹤0.01%	1353

Other funds holding AMAG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

LS Investment Advisors's AMAG Position: Q3 2020 in Review

LS Investment Advisors sold out of AMAG Pharmaceuticals (AMAG) in Q3 2020, closing a stake of 1,028 shares — an estimated $8K sold.

LS Investment Advisors first reported a position in AMAG in Q1 2016 and held it in 10 quarters. The position peaked at $81K in Q3 2017. 113 funds tracked by Wall St. Rank hold AMAG as of Q3 2020.

LS Investment Advisors reported no remaining AMAG Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
LS Investment Advisors sold 1,028 AMAG Pharmaceuticals shares in Q3 2020, an estimated $8K.
LS Investment Advisors first reported a position in AMAG Pharmaceuticals in Q1 2016 and held it in 10 quarters.
LS Investment Advisors's AMAG Pharmaceuticals position peaked at $81K in Q3 2017.
113 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q3 2020.

Based on LS Investment Advisors's 13F filing for Q3 2020, filed 12 Nov 2020.